These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33180095)

  • 1. Diagnostic performance of salivary pepsin for gastroesophageal reflux disease.
    Yadlapati R; Kaizer A; Greytak M; Ezekewe E; Simon V; Wani S
    Dis Esophagus; 2021 Apr; 34(4):. PubMed ID: 33180095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic thresholds and optimal collection protocol of salivary pepsin for gastroesophageal reflux disease.
    Ma SD; Patel VG; Greytak M; Rubin JE; Kaizer AM; Yadlapati RH
    Dis Esophagus; 2023 Mar; 36(4):. PubMed ID: 36148576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.
    Wang YJ; Lang XQ; Wu D; He YQ; Lan CH; Xiao X; Wang B; Zou DW; Wu JM; Zhao YB; Dettmar PW; Chen DF; Yang M
    J Neurogastroenterol Motil; 2020 Jan; 26(1):74-84. PubMed ID: 31650768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
    Guo Z; Wu Y; Chen J; Zhang S; Zhang C
    Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Salivary Pepsin to Detect Gastroesophageal Reflux Disease Is Not Ready for Clinical Application.
    Woodland P; Singendonk MMJ; Ooi J; Nikaki K; Wong T; Lee C; Glasinovic E; Koning R; Lutter R; Benninga MA; van Wijk MP; Sifrim D
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):563-565. PubMed ID: 29782998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China.
    Du X; Wang F; Hu Z; Wu J; Wang Z; Yan C; Zhang C; Tang J
    BMC Gastroenterol; 2017 Oct; 17(1):107. PubMed ID: 29041918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva pepsin measurements in the detection of gastroesophageal reflux disease in laryngopharyngeal reflux patients: a cohort study.
    Lechien JR; Bobin F
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3765-3771. PubMed ID: 37140740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease.
    Hayat JO; Gabieta-Somnez S; Yazaki E; Kang JY; Woodcock A; Dettmar P; Mabary J; Knowles CH; Sifrim D
    Gut; 2015 Mar; 64(3):373-80. PubMed ID: 24812000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroesophageal reflux disease and salivary pepsin in patients with heterotopic gastric mucosa in the upper esophagus.
    Xiong X; He S; Xu F; Xu Z; Zhang X; Wang H; Liu T; Jia Y
    Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34750620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease.
    Saritas Yuksel E; Hong SK; Strugala V; Slaughter JC; Goutte M; Garrett CG; Dettmar PW; Vaezi MF
    Laryngoscope; 2012 Jun; 122(6):1312-6. PubMed ID: 22447277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
    Roorda AK; Marcus SN; Triadafilopoulos G
    Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical application value of salivary pepsin in the diagnosis of gastroesophageal reflux diseases.
    Chen R; Shi L; Huang X; Mao H; Feng B; Wang M; Lin L; Jiang L
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14627. PubMed ID: 37332241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The characteristics of esophagogastric junction contractile index in patients with gastroesophageal reflux disease or functional heartburn].
    Wang K; Duan LP; Ge Y; Xia ZW; Xu ZJ
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):283-8. PubMed ID: 27030616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.
    Dy F; Amirault J; Mitchell PD; Rosen R
    J Pediatr; 2016 Oct; 177():53-58. PubMed ID: 27453366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abilities of Oropharyngeal pH Tests and Salivary Pepsin Analysis to Discriminate Between Asymptomatic Volunteers and Subjects With Symptoms of Laryngeal Irritation.
    Yadlapati R; Adkins C; Jaiyeola DM; Lidder AK; Gawron AJ; Tan BK; Shabeeb N; Price CP; Agrawal N; Ellenbogen M; Smith SS; Bove M; Pandolfino JE
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):535-542.e2. PubMed ID: 26689899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between salivary pepsin and gastroesophageal reflux disease: A meta-analysis.
    Han F; Li X; Song Z; Xie J; Wang N; Yao J
    Neurogastroenterol Motil; 2024 Nov; 36(11):e14905. PubMed ID: 39223797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value associated with the combination of saliva pepsin and microorganisms in functional heartburn and gastroesophageal reflux disease.
    Huang YQ; Yang C; Luo W
    World J Gastroenterol; 2024 May; 30(19):2612-2614. PubMed ID: 38817654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.